for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Blackmores Limited

BKL.AX

Latest Trade

84.55AUD

Change

1.55(+1.87%)

Volume

66,624

Today's Range

83.01

 - 

84.55

52 Week Range

63.64

 - 

133.10

As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay

Pricing

Previous Close
83.00
Open
83.19
Volume
66,624
3M AVG Volume
1.31
Today's High
84.55
Today's Low
83.01
52 Week High
133.10
52 Week Low
63.64
Shares Out (MIL)
17.36
Market Cap (MIL)
1,470.77
Forward P/E
29.88
Dividend (Yield %)
2.60

Next Event

Half Year 2020 Blackmores Ltd Earnings Release

Latest Developments

更多

Blackmores Says Gunther Burghardt To Join As New Group Chief Financial Officer

Blackmores Says Brent Wallace Retires As Chairman

Blackmores Completes Acquisition Of Braeside Manufacturing Facility

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Blackmores Limited

Blackmores Limited is engaged in the development, sales and marketing of health products for humans and animals, including vitamins, herbal and mineral nutritional supplements. The Company's segments include Australia, China (in-country), Other Asia, BioCeuticals and Other. The Company offers over 250 vitamins, minerals, herbal and nutritional supplements. BioCeuticals is a provider of healthcare practitioner nutritional and therapeutic supplements. Its product categories include pet health; infant formula; superfoods; arthritis, joint, bone and muscle; brain health; cold, flu and immunity; digestive health; energy and exercise; eye health; everyday health; fish and nutritional oils; heart and circulation; men's health; nails, hair and skin; pregnancy and pre-conception; stress relief, and weight management. Its products include Acidophilus Bifidus, Alive! Men's 50+ Multivitamin, Alive! Women's 50+ Multivitamin, Alive! Women's Multivitamin and Bilberry Eyestrain Relief.

Industry

Biotechnology & Drugs

Contact Info

20 Jubilee Ave

+61.2.99105000

https://www.blackmores.com.au/

Executive Leadership

Brent W. Wallace

Chairman of the Board

Alastair Symington

Chief Executive Officer, Managing Director, Director

Aaron Canning

Chief Financial Officer, Joint Company Secretary

Jeremy Cowan

Chief Operations Officer

Brett Winn

Chief Information Officer

Key Stats

3.60 mean rating - 10 analysts
Sell
Hold
Buy
Revenue (MM, AUD)

2017

0.7K

2018

0.6K

2019

0.6K

2020(E)

0.7K
EPS (AUD)

2017

3.401

2018

4.057

2019

3.092

2020(E)

2.830
Price To Earnings (TTM)
27.39
Price To Sales (TTM)
2.41
Price To Book (MRQ)
7.08
Price To Cash Flow (TTM)
22.87
Total Debt To Equity (MRQ)
57.41
LT Debt To Equity (MRQ)
57.41
Return on Investment (TTM)
16.96
Return on Equity (TTM)
11.18

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up